China Sxt Pharmaceuticals

(NASDAQ) SXTC

Current Price$2.55

Market Cap$82.16M

Since IPO (2019)-100%

5 Year-100%

1 Year-99%

1 Month-1%

China Sxt Pharmaceuticals Financials at a Glance

Market Cap

$82.16M

Revenue (TTM)

$2.54M

Net Income (TTM)

-$7.37M

EPS (TTM)

-$8.06

P/E Ratio

-0.32

Dividend

$0.00

Beta (Volatility)

1.90 (High)

Dividend

$0.00

Beta (Volatility)

1.90 (High)

Price

$2.55

Volume

104

Open

$2.52

Price

$2.55

Volume

104

Open

$2.52

Previous Close

$2.55

Daily Range

$2.52 - $2.55

52-Week Range

$1.25 - $1,046.99

Estimated Earnings Date

Jul 17, 2023

Dividend

$0.00

Beta (Volatility)

1.90 (High)

Price

$2.55

Volume

104

Open

$2.52

Previous Close

$2.55

Daily Range

$2.52 - $2.55

52-Week Range

$1.25 - $1,046.99

Estimated Earnings Date

Jul 17, 2023

SXTC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About China Sxt Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Sze Beng Lim; Feng Zhou

Website

www.sxtchina.com

Headquarters

Taizhou, JS 225300, CN

SXTC Financials

Key Financial Metrics (TTM)

Gross Margin

44.37%

Operating Margin

-336.53%

Net Income Margin

-290.71%

Return on Equity

-31.02%

Return on Capital

-23.11%

Return on Assets

-21.22%

Earnings Yield

-3.13%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$82.16M

Shares Outstanding

32.22M

Volume

104

Avg. Volume

65.91K

Financials (TTM)

Gross Profit

$1.13M

Operating Income

-$8.54M

EBITDA

-$8.37M

Operating Cash Flow

-$6.14M

Capital Expenditure

$988.15K

Free Cash Flow

-$5.15M

Cash & ST Invst.

$28.18M

Total Debt

$1.12M

China Sxt Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2026YOY CHG

Revenue

$1.20M

+163.0%

Gross Profit

$833.97K

+616.9%

Gross Margin

69.59%

N/A

Market Cap

$82.16M

N/A

Market Cap/Employee

$1.47M

N/A

Employees

N/A

Net Income

$163.72K

+113.1%

EBITDA

-$672.89K

+33.7%

Quarterly Fundamentals

Name

Q4 2026YOY CHG

Total Cash

$28.18M

+54.5%

Total Debt

$1.12M

+13.9%

Accounts Receivable

$3.23M

+148.4%

Inventory

$2.96M

+161.8%

Long Term Debt

$697.83K

+229.7%

Short Term Debt

$423.15K

-45.2%

Return on Assets

-21.22%

N/A

Return on Invested Capital

-28.07%

N/A

Free Cash Flow

-$2.26M

-214.2%

Operating Cash Flow

-$2.26M

-214.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ATLNAtlantic International Corp.

ATLNAtlantic International Corp.$0.90+0.00%

SAVACassava Sciences, Inc.

SAVACassava Sciences, Inc.$1.32+2.33%

MISTMilestone Pharmaceuticals Inc.

MISTMilestone Pharmaceuticals Inc.$1.28+0.00%

IXHLIncannex Healthcare Limited

IXHLIncannex Healthcare Limited$3.31-2.36%

IPHAInnate Pharma S.A.

IPHAInnate Pharma S.A.$1.79-0.14%

TNXPTonix Pharmaceuticals Holding Corp.

TNXPTonix Pharmaceuticals Holding Corp.$11.71-6.58%

AVRAnteris Technologies Global Corp.

AVRAnteris Technologies Global Corp.$9.36-4.20%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$72.64-0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.95+0.06%

SKHYSK Hynix

SKHYSK Hynix$152.35-0.09%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.27-0.06%

NOKNokia

NOKNokia$11.69-0.06%

ORCLOracle

ORCLOracle$131.54-0.06%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$35.22-0.03%

Questions About SXTC

What is the current price of China Sxt Pharmaceuticals?

China Sxt Pharmaceuticals is trading at $2.55 per share.

What is the 52-week range for China Sxt Pharmaceuticals?

Over the past 52 weeks, China Sxt Pharmaceuticals has traded between $1.25 and $1,046.99.

How much debt does China Sxt Pharmaceuticals have?

As of the most recent reporting period, China Sxt Pharmaceuticals reported total debt of $1.12M.

How much cash does China Sxt Pharmaceuticals have on hand?

China Sxt Pharmaceuticals reported $28.18M in cash and cash equivalents in its most recent financial results.

What is China Sxt Pharmaceuticals’s dividend yield?

China Sxt Pharmaceuticals does not currently have a dividend yield.

China Sxt Pharmaceuticals

China Sxt Pharmaceuticals Financials at a Glance

SXTC News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About China Sxt Pharmaceuticals

SXTC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

China Sxt Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SXTC

What is the current price of China Sxt Pharmaceuticals?

What is the 52-week range for China Sxt Pharmaceuticals?

How much debt does China Sxt Pharmaceuticals have?

How much cash does China Sxt Pharmaceuticals have on hand?

What is China Sxt Pharmaceuticals’s dividend yield?

Premium Investing Services